Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lixte Biotechnology Holdings Inc.

1.13
-0.0946-7.72%
Post-market: 1.180.0486+4.30%16:00 EDT
Volume:458.00
Turnover:541.82
Market Cap:3.04M
PE:-0.71
High:1.22
Open:1.22
Low:1.13
Close:1.23
Loading ...

Lixte Biotechnology Provides Update on Progress With Proprietary Compound, Lb-100, to Treat Ovarian and Colorectal Cancer

THOMSON REUTERS
·
27 Mar

LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer

GlobeNewswire
·
27 Mar

BRIEF-Lixte Biotechnology terminates sales agreement with Wallachbeth Capital

Reuters
·
11 Mar

Lixte Adds NorthWestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

THOMSON REUTERS
·
25 Feb

LIXTE Adds Northwestern University’s Lurie Cancer Center as Second Site in Ongoing Clinical Trial for Ovarian Clear Cell Cancer

GlobeNewswire
·
25 Feb

Lixte Biotechnology Closes $1.1 Million Direct Offering

MT Newswires Live
·
14 Feb

Lixte Biotechnology announces closing of $1.05M registered direct offering

TIPRANKS
·
13 Feb

Lixte Biotechnology Announces Closing of $1.05 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
13 Feb

Lixte Biotechnology Announces $1.05 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
11 Feb

LIXTE Biotechnology Announces $1.05 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

GlobeNewswire
·
11 Feb

Lixte Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

THOMSON REUTERS
·
11 Feb

LIXTE Biotechnology Submits Request for Withdrawal of Form S-1 Registration Statement

GlobeNewswire
·
11 Feb

BRIEF-Lixte Biotechnology Holdings' Eric Forman Resigns As VP And COO Of Lixte Biotech Effective As Of Dec 31

Reuters
·
28 Dec 2024

Lixte Biotechnology Holdings - on Dec 23, Eric Forman Resigns as Vp and COO of Lixte Biotech Effective as of Dec 31

THOMSON REUTERS
·
28 Dec 2024